Silibinin ameliorates steatosis and insulin resistance...

Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway

Zhang, Yongxiang, Hai, Jie, Cao, Meng, Zhang, Yongli, Pei, Sujuan, Wang, Junbo, Zhang, Qinggui
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
International Immunopharmacology
DOI:
10.1016/j.intimp.2013.08.019
Date:
November, 2013
File:
PDF, 1.65 MB
english, 2013
Conversion to is in progress
Conversion to is failed